The Terasaki Innovation Summit aims to improve the technological, entrepreneurial translation of personalized medicine.

[ad_1]

The Terasaki Institute for Biomedical Innovation (TIBI) will host the Terasaki Innovation Summit March 8-10, 2023 at the UCLA Meyer & Renee Luskin Center in Los Angeles. This inaugural event aims to advance the technological and entrepreneurial translation of personalized medicine – bringing biomedical innovation from the lab to the real world.

The Terasaki Innovation Summit, featuring thought leaders and innovators who will discuss the future of biomedicine, bring ideas from the bench to the bedside, and discuss the creation and funding of spin-off companies, the Terasaki Innovation Summit is essential for academics interested in commercializing their technologies and industry participants who want to learn about the latest developments. technologies in personalized medicine offered by the academy.

Many technologies die on the vine due to the gap between industry and academia and the enormous barriers that make licensing technologies difficult. The Terasaki Innovation Summit aims to help innovators close those gaps to bring new personalized and precision medicines to market, and to help celebrate the legacy of our founder, who successfully developed important organ transplant technologies that patients still use today.”

Ali Khademhosseini, Ph.D., Director and CEO of TIBI

Focused on translating innovations in personalized medicine

Leading researchers at the inaugural Terasaki Innovation Summit will discuss the latest advances in micro- and nanotechnology and applications in diagnostics, drug delivery and regenerative medicine. In addition, translation, innovation, venture investment, IP, etc. Key business leaders and experts in the field share their knowledge and commercial experience.

Thought leaders will share their cutting-edge work and ground-breaking innovations with keynote speakers, including:

Joseph DeSimone, Stanford professor, whose research focuses on developing new vaccine platforms for pediatrics.

Peter Diamandis, leading entrepreneur, technology innovation consultant and founder of XPRIZE

Robert Langer, MIT professor, prolific researcher, legendary pioneer of new biomedical technologies, and founder of more than forty biotech companies

Samir Mitragotri, Ph.D., is a renowned researcher in the field of drug delivery and biological barriers

Xiling Shen, Ph.D., Xilis, Inc. Founder and CEO and Chief Scientific Officer of TIBI

Introducing the Paul Terasaki and Hisako Terasaki Youth Awards

The Terasaki Innovation Summit will also mark the debut of new awards for innovators, including the Paul Terasaki Award, which recognizes an innovator with a $25,000 grant, and the Hisako Terasaki Young Innovator Travel Award, which recognizes young innovators in the industry with travel reimbursement. expenses.

Participation in the Terasaki Innovation Summit

The Terasaki Innovation Summit, March 8-10, 2023 at UCLA’s Luskin Conference Center in Los Angeles, promises to be a unique gathering of some of the most prominent names in biomedical engineering. information and networking opportunities with others in the scientific community. Investors, industry and academics interested in participating can register at the following link, with discounts for students and academics: https://whova.com/portal/registration/tibi_202303/

Early bird registration closes on November 18, 2022.

Source:

Terasaki Institute for Biomedical Innovation

[ad_2]

Source link